Food Intolerance — Athlete Whey Protein Sensitivity: Prevalence and Performance
Citation(s)
Anthoni S, Savilahti E, Rautelin H, Kolho KL Milk protein IgG and IgA: the association with milk-induced gastrointestinal symptoms in adults. World J Gastroenterol. 2009 Oct 21;15(39):4915-8. doi: 10.3748/wjg.15.4915.
Antico A, Pagani M, Vescovi PP, Bonadonna P, Senna G Food-specific IgG4 lack diagnostic value in adult patients with chronic urticaria and other suspected allergy skin symptoms. Int Arch Allergy Immunol. 2011;155(1):52-6. doi: 10.1159/000318736. Epub 2010 Nov 26.
de Oliveira EP, Burini RC, Jeukendrup A Gastrointestinal complaints during exercise: prevalence, etiology, and nutritional recommendations. Sports Med. 2014 May;44 Suppl 1(Suppl 1):S79-85. doi: 10.1007/s40279-014-0153-2.
Garza B, Ege T, Ramos S, Lockard B Comparison of Actual versus Recommended Intake of Collegiate Athletes Across Gender and Season at a Small Division I University. International Journal of Exercise Science: Conference Proceedings, 2022.
Jenni WHOOP Strain. Retrieved April 22, 2022, from https://support.whoop.com/hc/en-us/articles/360019453214-WHOOP-Strain
Klavora, P Vertical-jump Tests: A Critical Review. Strength and Conditioning Journal. October 2000 22:5.
Lambert GP Intestinal barrier dysfunction, endotoxemia, and gastrointestinal symptoms: the 'canary in the coal mine' during exercise-heat stress? Med Sport Sci. 2008;53:61-73. doi: 10.1159/000151550.
Lee LA, Burks AW Food allergies: prevalence, molecular characterization, and treatment/prevention strategies. Annu Rev Nutr. 2006;26:539-65. doi: 10.1146/annurev.nutr.26.061505.111211.
Lim MT, Pan BJ, Toh DWK, Sutanto CN, Kim JE Animal Protein versus Plant Protein in Supporting Lean Mass and Muscle Strength: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2021 Feb 18;13(2):661. doi: 10.3390/nu13020661.
Ling CH, de Craen AJ, Slagboom PE, Gunn DA, Stokkel MP, Westendorp RG, Maier AB Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr. 2011 Oct;30(5):610-5. doi: 10.1016/j.clnu.2011.04.001. Epub 2011 May 8.
Ozdemir O, Mete E, Catal F, Ozol D Food intolerances and eosinophilic esophagitis in childhood. Dig Dis Sci. 2009 Jan;54(1):8-14. doi: 10.1007/s10620-008-0331-x. Epub 2008 Jul 2.
Stockton S, Breshears K, Baker DM The Impact of a Food Elimination Diet on Collegiate Athletes' 300-meter Run Time and Concentration. Glob Adv Health Med. 2014 Nov;3(6):25-40. doi: 10.7453/gahmj.2014.046.
Van Deusen, M Heart Rate Variability | The Ultimate Guide to HRV. 2022, 2021.
Zhou LM, Xu JY, Rao CP, Han S, Wan Z, Qin LQ Effect of whey supplementation on circulating C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients. 2015 Feb 9;7(2):1131-43. doi: 10.3390/nu7021131.
Zopf Y, Baenkler HW, Silbermann A, Hahn EG, Raithel M The differential diagnosis of food intolerance. Dtsch Arztebl Int. 2009 May;106(21):359-69; quiz 369-70; 4 p following 370. doi: 10.3238/arztebl.2009.0359. Epub 2009 May 22.
Athlete Whey Protein Sensitivity: Prevalence and Performance
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.